Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients
- PMID: 21044966
- PMCID: PMC2982808
- DOI: 10.1093/jnci/djq370
Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients
Abstract
Background: MUTYH-associated polyposis is a recessively inherited disorder characterized by a lifetime risk of colorectal cancer that is up to 100%. Because specific histological and molecular genetic features of MUTYH-associated polyposis colorectal cancers might influence tumor behavior and patient survival, we compared survival between patients with MUTYH-associated polyposis colorectal cancer and matched control patients with colorectal cancer from the general population.
Methods: In this retrospective multicenter cohort study from Europe, 147 patients with MUTYH-associated polyposis colorectal cancer were compared with 272 population-based control patients with colorectal cancer who were matched for country, age at diagnosis, year of diagnosis, stage, and subsite of colorectal cancer. Kaplan-Meier survival and Cox regression analyses were used to compare survival between patients with MUTYH-associated polyposis colorectal cancer and control patients with colorectal cancer. All statistical tests were two-sided.
Results: Five-year survival for patients with MUTYH-associated polyposis colorectal cancer was 78% (95% confidence interval [CI] = 70% to 84%) and for control patients was 63% (95% CI = 56% to 69%) (log-rank test, P = .002). After adjustment for differences in age, stage, sex, subsite, country, and year of diagnosis, survival remained better for MUTYH-associated polyposis colorectal cancer patients than for control patients (hazard ratio of death = 0.48, 95% CI = 0.32 to 0.72).
Conclusions: In a European study cohort, we found statistically significantly better survival for patients with MUTYH-associated polyposis colorectal cancer than for matched control patients with colorectal cancer.
Figures
Comment in
-
Colorectal cancer survival advantage in MUTYH-associated polyposis and Lynch syndrome families.J Natl Cancer Inst. 2010 Nov 17;102(22):1687-9. doi: 10.1093/jnci/djq439. Epub 2010 Nov 2. J Natl Cancer Inst. 2010. PMID: 21044965 No abstract available.
References
-
- Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(3):74–108. - PubMed
-
- Sankila R, Aaltonen LA, Jarvinen HJ, et al. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996;110(3):682–687. - PubMed
-
- Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998;83(2):259–266. - PubMed
-
- Lynch HT, Bardawil WA, Harris RE, et al. Multiple primary cancers and prolonged survival: familial colonic and endometrial cancers. Dis Colon Rectum. 1978;21(3):165–168. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
